ClearBridge Investments’s PDL BioPharma, Inc. PDLI Stock Holding History

ClearBridge Investments’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-101	Closed	-$1K	–	1195
2016 Q3	$1K	Hold	101	–	–	﹤0.01%	1114
2016 Q2	$1K	Hold	101	–	–	﹤0.01%	1062
2016 Q1	$1K	Hold	101	–	–	﹤0.01%	1055
2015 Q4	$1K	Hold	101	–	–	﹤0.01%	1114
2015 Q3	$1K	Hold	101	–	–	﹤0.01%	1171
2015 Q2	$1K	Hold	101	–	–	﹤0.01%	1152
2015 Q1	$1K	Hold	101	–	–	﹤0.01%	1169
2014 Q4	$1K	Hold	101	–	–	﹤0.01%	1169
2014 Q3	$1K	Hold	101	–	–	﹤0.01%	1160
2014 Q2	$1K	Hold	101	–	–	﹤0.01%	1170
2014 Q1	$1K	Hold	101	–	–	﹤0.01%	1129
2013 Q4	$1K	Hold	101	–	–	﹤0.01%	1098
2013 Q3	$1K	Hold	101	–	–	﹤0.01%	1083
2013 Q2	$1K	Buy	+101	New	+$788	﹤0.01%	1062

Other funds holding PDLI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

ClearBridge Investments's PDLI Position: Q4 2016 in Review

ClearBridge Investments sold out of PDL BioPharma, Inc. (PDLI) in Q4 2016, closing a stake of 101 shares — an estimated $1K sold.

ClearBridge Investments first reported a position in PDLI in Q2 2013 and held it in 14 quarters. The position peaked at $1K in Q3 2016. 190 funds tracked by Wall St. Rank hold PDLI as of Q4 2016.

ClearBridge Investments reported no remaining PDL BioPharma, Inc. position as of Q4 2016 after selling out during the quarter.
ClearBridge Investments sold 101 PDL BioPharma, Inc. shares in Q4 2016, an estimated $1K.
ClearBridge Investments first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 14 quarters.
ClearBridge Investments's PDL BioPharma, Inc. position peaked at $1K in Q3 2016.
190 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2016.

Based on ClearBridge Investments's 13F filing for Q4 2016, filed 14 Feb 2017.